Filter posts

Dr. Scott Gottlieb: A Clintonian Misdirection on Drug Prices

Today’s Wall Street Journal contains an excellent op-ed by Dr. Scott Gottlieb, a physician and …

Discover Trends and Investment Opportunities at the BIO Investor Forum

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event …

Wall Street Journal: The Assault on Drug Innovation

Today, the Wall Street Journal published an editorial commenting on yesterday’s proposed plan by Secretary Hillary Clinton’s …

BIO Statement on Patient Access to Medicines

“As a general policy, BIO does not comment on matters related to individual company products …

Reality Check for AHIP: Competition Driving Down Costs for Hepatitis C Meds

Yesterday at a House Judiciary Committee hearing on competition in the healthcare marketplace, AHIP Executive Vice …

BIO Statement: Institute for Clinical and Economic Review Framework

This week, the Institute for Clinical and Economic Review (ICER) released its Value Assessment Framework. …

Health Affairs Study: Want to save money in Medicaid? Increase adherence.

At BIO, we have long argued that the use of prescription medicines can yield substantial …

International Day of Charity

While most of us are well-aware of the Labor Day holiday we celebrated this weekend, …

Politico: Carter's Cancer Care Reflects Improved Drug Treatments

This week, Politico’s Jason Millman highlights the treatment and care that Jimmy Carter is receiving …

Congress Blog: Medical Advances Keep Me Running

This week, 74-year-old multiple myeloma patient Don Wright shares his story on how cancer drugs have …